Study on the role of human herpesvirus-6 infection in cutaneous drug eruptions

YUAN Wei-ru,LI Wei-ping,XUE Feng,SHI Ruo-fei,ZHENG Jie

2009-01-01

Abstract:Objective To investigate the role of human herpesvirus-6 (HHV-6) in cutaneous drug eruptions. Methods One hundred and twenty-seven patients with cutaneous drug eruptions and 67 healthy controls were enrolled in the study. Real-time polymerase chain reaction (PCR) was performed for the assessment of HHV-6 DNA in serum of the patients and the healthy controls. HHV-6 IgG and IgM antibody levels were measured by ELISA. Results Fifteen patients (11.8%)had active HHV-6 infection,of whom drug-induced hypersensitivity syndrome (DIHS) was the most frequent (46.7%). Besides,HHV-6 infection had also been demonstrated in exanthematous eruptions (EE),erythema multiforme (EM),Stevens-Johnson syndrome (SJS) and exfoliative dermatitis (ED). The males were more likely to have active HHV-6 infection (P<0.05). The incidence of DIHS was higher in the patients with HHV-6 infection than those without HHV-6 infection (P<0.01). The patients who had HHV-6 infection were more susceptible to fever (P<0.05),lymphadenopathy,liver and renal function insufficiency and eosinophilia (P<0.01). The latency or course for disease-controlling of patients with HHV-6 infection was significantly longer than that of those without HHV-6 infection (P<0.01). The positive rate of HHV-6 IgG was higher in patients with cutaneous drug eruptions than that in healthy controls (P< 0.01). Conclusions HHV-6 infection played a role in cutaneous drug eruptions. HHV-6 infection is most frequent in DIHS,and then in EE,EM,SJS and ED. The development of DIHS is correlated with HHV-6 infection. HHV-6 infection might contribute to the severity,latency,prolonged course,and occurrence of complication of cutaneous drug eruptions. Cutaneous drug eruptions are prone to occur in patients with latent HHV-6 infection.